Frontiers | Developing Personalized Treatment in Neurodegenerative Disorders: Role of Genomics and Novel Technologies in Identifying Actionable Targets and Developing Interventions in Rare-Diseases

Developing Personalized Treatment in Neurodegenerative Disorders: Role of Genomics and Novel Technologies in Identifying Actionable Targets and Developing Interventions in Rare-Diseases

3,850
Total downloads
12k
Total views and downloads

Articles

EDITORIAL

Published on 09 Apr 2024

Editorial: Developing personalized treatment in neurodegenerative disorders: role of genomics and novel technologies in identifying actionable targets and developing interventions in rare-diseases

Anja Kovanda
Sabina Vatovec
Valentino Rački

doi 10.3389/fnins.2024.1403015

526 views

ORIGINAL RESEARCH

Published on 28 Nov 2023

Freezing of gait in Parkinson’s disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life

Ruwei Ou
Chunyu Li
Qianqian Wei
Kuncheng Liu
Junyu Lin
Tianmi Yang
Yi Xiao
Qirui Jiang
Yangfan Cheng
5 more
Huifang Shang

Freezing of gait in Parkinson’s disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life

doi 10.3389/fnins.2023.1288631

1,218 views
1 citation

PERSPECTIVE

Published on 10 Nov 2023

Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson’s disease and monogenic dystonia: a multidisciplinary team perspective

Valentino Rački
Mario Hero
Eliša Papić
Gloria Rožmarić
Nada Starčević Čizmarević
Darko Chudy
Borut Peterlin
Vladimira Vuletić

Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson’s disease and monogenic dystonia: a multidisciplinary team perspective

doi 10.3389/fnins.2023.1282267

1,566 views

ORIGINAL RESEARCH

Published on 11 Jan 2023

Third-generation genome sequencing implicates medium-sized structural variants in chronic schizophrenia

Chi Chiu Lee
Rui Ye
Justin D. Tubbs
Larry Baum
Yuanxin Zhong
Shuk Yan Joey Leung
Sheung Chun Chan
Kit Ying Kitty Wu
Po Kwan Jamie Cheng
2 more
Pak Chung Sham

Third-generation genome sequencing implicates medium-sized structural variants in chronic schizophrenia

doi 10.3389/fnins.2022.1058359

2,609 views
3 citations

REVIEW

Published on 03 Nov 2022

MS-based glycomics: An analytical tool to assess nervous system diseases

Wenjing Peng
Firas Kobeissy
Stefania Mondello
Chloe Barsa
Yehia Mechref

MS-based glycomics: An analytical tool to assess nervous system diseases

doi 10.3389/fnins.2022.1000179

3,043 views
14 citations

Share on

Frontiers in Neuroscience

Frontiers in Neuroscience

Translational Neuroscience

Impact

12kTopic views
7,697Article views
3,850Article downloads